BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...officer. Berns was VP, chief compliance officer and legal affairs at AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). Oncopeptides AB...
...Sawka, BioCentury Staff BeiGene Ltd. Sarepta Therapeutics Inc. RegenxBio Inc. BioMarin Pharmaceutical Inc. Novavax Inc. Whitehead Institute for Biomedical Research Akcea Therapeutics Inc. Oncopeptides AB Codiak...
BioCentury | Mar 4, 2020
Management Tracks

Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more

...He was senior director of new product strategy at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). Cancer company Oncopeptides AB...
...Staff Applied Therapeutics Inc. twoXAR Inc. Rafael Pharmaceuticals Inc. Addex Therapeutics Ltd. Celyad S.A. Sumitomo Dainippon Pharma Co. Ltd. Acacia Pharma Group plc Oncopeptides AB Biogen...
BioCentury | Sep 16, 2019
Clinical News

Data for Oncopeptides' melflufen could support broader MM label

...approval in triple-class refractory MM, CEO Jakob Lindberg said on a conference call Monday. If Oncopeptides AB...
...MM patients refractory to Revlimid lenalidomide. Oncopeptides added SEK1.30 to SEK133.30 on Monday. Paul Bonanos, Associate Editor Oncopeptides AB...
BioCentury | Sep 13, 2019
Company News

Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more

...was co-founder, CSO and CEO of Akinion Pharmaceuticals AB (Solna, Sweden). Harmenberg is CMO at Oncopeptides AB...
BioCentury | Aug 20, 2019
Company News

Management tracks: uniQure, Provention, Anaptys, FDA and more

...regulatory lead at the Kite Pharma Inc. subsidiary of Gilead Sciences Inc. (NASDAQ:GILD). Cancer company Oncopeptides AB...
...First Analysis Securities Corp. Jonathan Block, Associate Editor AnaptysBio Inc. Marker Therapeutics Inc. Merz GmbH & Co. KGaA Nordic Nanovector ASA Oncopeptides AB Provention...
BioCentury | Aug 10, 2018
Company News

Management tracks: Oncopeptides, Merz

...Cancer company Oncopeptides AB (SSE:ONCO) said CFO Birgitta Ståhl has stepped down. She is succeeded by Anders...
BioCentury | Apr 22, 2017
Finance

Sweden heating up

...disease play Wilson Therapeutics AB (SSE:WTX), antibody company Alligator Bioscience AB (SSE:ATORX) and oncology play Oncopeptides AB...
...First North or Stockholm exchanges this year have raised SEK1.3 billion ($144.2 million). Cancer play Oncopeptides AB...
...SEK800 -13% $88.3 Biovica International AB (SSE:BIOVIC B) Diagnostic 3/28/17 SEK60 SEK102 SEK97 -5% $10.7 Oncopeptides AB...
BioCentury | Apr 7, 2017
Finance

Taking notice

...NASDAQ:BYSI) (A) 3/9/17 $3.5 $434.2 $432.6 0% PCL Inc. (KOSDAQ:241820) 2/23/17 $10.8 $64.2 $61.2 -5% Oncopeptides AB...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides raises SEK650M in IPO

...study of Ygalo melflufen to treat multiple myeloma (MM). Ygalo is a prodrug of melphalan. Becky Simon melflufen Oncopeptides AB...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides completes IPO

...On Feb. 22, cancer company Oncopeptides AB (SSE:ONCO) raised SEK650 million ($72.7 million) through the sale of...
...underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB Markets. Oncopeptides AB (SSE:ONCO), Stockholm, Sweden Alex Himes Oncopeptides AB...
Items per page:
1 - 10 of 21
BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...officer. Berns was VP, chief compliance officer and legal affairs at AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). Oncopeptides AB...
...Sawka, BioCentury Staff BeiGene Ltd. Sarepta Therapeutics Inc. RegenxBio Inc. BioMarin Pharmaceutical Inc. Novavax Inc. Whitehead Institute for Biomedical Research Akcea Therapeutics Inc. Oncopeptides AB Codiak...
BioCentury | Mar 4, 2020
Management Tracks

Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more

...He was senior director of new product strategy at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). Cancer company Oncopeptides AB...
...Staff Applied Therapeutics Inc. twoXAR Inc. Rafael Pharmaceuticals Inc. Addex Therapeutics Ltd. Celyad S.A. Sumitomo Dainippon Pharma Co. Ltd. Acacia Pharma Group plc Oncopeptides AB Biogen...
BioCentury | Sep 16, 2019
Clinical News

Data for Oncopeptides' melflufen could support broader MM label

...approval in triple-class refractory MM, CEO Jakob Lindberg said on a conference call Monday. If Oncopeptides AB...
...MM patients refractory to Revlimid lenalidomide. Oncopeptides added SEK1.30 to SEK133.30 on Monday. Paul Bonanos, Associate Editor Oncopeptides AB...
BioCentury | Sep 13, 2019
Company News

Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more

...was co-founder, CSO and CEO of Akinion Pharmaceuticals AB (Solna, Sweden). Harmenberg is CMO at Oncopeptides AB...
BioCentury | Aug 20, 2019
Company News

Management tracks: uniQure, Provention, Anaptys, FDA and more

...regulatory lead at the Kite Pharma Inc. subsidiary of Gilead Sciences Inc. (NASDAQ:GILD). Cancer company Oncopeptides AB...
...First Analysis Securities Corp. Jonathan Block, Associate Editor AnaptysBio Inc. Marker Therapeutics Inc. Merz GmbH & Co. KGaA Nordic Nanovector ASA Oncopeptides AB Provention...
BioCentury | Aug 10, 2018
Company News

Management tracks: Oncopeptides, Merz

...Cancer company Oncopeptides AB (SSE:ONCO) said CFO Birgitta Ståhl has stepped down. She is succeeded by Anders...
BioCentury | Apr 22, 2017
Finance

Sweden heating up

...disease play Wilson Therapeutics AB (SSE:WTX), antibody company Alligator Bioscience AB (SSE:ATORX) and oncology play Oncopeptides AB...
...First North or Stockholm exchanges this year have raised SEK1.3 billion ($144.2 million). Cancer play Oncopeptides AB...
...SEK800 -13% $88.3 Biovica International AB (SSE:BIOVIC B) Diagnostic 3/28/17 SEK60 SEK102 SEK97 -5% $10.7 Oncopeptides AB...
BioCentury | Apr 7, 2017
Finance

Taking notice

...NASDAQ:BYSI) (A) 3/9/17 $3.5 $434.2 $432.6 0% PCL Inc. (KOSDAQ:241820) 2/23/17 $10.8 $64.2 $61.2 -5% Oncopeptides AB...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides raises SEK650M in IPO

...study of Ygalo melflufen to treat multiple myeloma (MM). Ygalo is a prodrug of melphalan. Becky Simon melflufen Oncopeptides AB...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides completes IPO

...On Feb. 22, cancer company Oncopeptides AB (SSE:ONCO) raised SEK650 million ($72.7 million) through the sale of...
...underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB Markets. Oncopeptides AB (SSE:ONCO), Stockholm, Sweden Alex Himes Oncopeptides AB...
Items per page:
1 - 10 of 21